ARCUTIS BIOTHERAPEUTIC
10.15
20-9月-24 15:59:59
15 分の遅延
株式
+0.01
+0.10%
本日の幅
9.78 - 10.31
ISIN
N/A
ソース
NASDAQ
-
29 1 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
22 1 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
14 1 2024 04:00:00 提供 Nasdaq GlobeNewswire
-
14 1 2024 04:00:00 提供 Nasdaq GlobeNewswire
-
15 12 2023 17:11:43 提供 Nasdaq GlobeNewswire
-
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01 12 2023 22:00:49 提供 Nasdaq GlobeNewswire
-
29 11 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
Arcutis Announces Third Quarter 2023 Financial Results and Provides Business Update
03 11 2023 07:30:00 提供 Nasdaq GlobeNewswire
-
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02 11 2023 16:00:00 提供 Nasdaq GlobeNewswire
-
Arcutis to Report Third Quarter 2023 Financial Results
25 10 2023 16:00:00 提供 Nasdaq GlobeNewswire
-
20 10 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
Arcutis Announces Pricing of $100 Million Public Offering
19 10 2023 23:45:47 提供 Nasdaq GlobeNewswire
-
Arcutis Announces Proposed Public Offering
19 10 2023 16:04:44 提供 Nasdaq GlobeNewswire
-
06 10 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05 10 2023 16:00:00 提供 Nasdaq GlobeNewswire
-
Arcutis Appoints L. Todd Edwards as Chief Commercial Officer
27 9 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
25 9 2023 09:00:47 提供 Nasdaq GlobeNewswire
-
19 9 2023 07:30:00 提供 Nasdaq GlobeNewswire
-
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
15 9 2023 16:00:00 提供 Nasdaq GlobeNewswire